- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 82.84M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $29.19M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $28.91M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $20.9M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $23.65M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $79.26M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $82.08M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $77.81M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $98.77M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $128.89M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $149.01M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $54.19M |
| Short Term Investments restated | Q1 2025 · Mar 31, 2024 | $27.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $19.26M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $58.05M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 69.85M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.13M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$7.79M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $79.27M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $86.62M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.16 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.16 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $12.86M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $11.25M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$11.51M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$11.89M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.86M |
| Revenue | Q1 2025 · Mar 31, 2024 | $17.07M |